Latest News

Adaptive Biotechnologies, a commercial-stage biotech focused on the adaptive immune system, recently highlighted very large year-on-year revenue growth alongside upcoming presentations at the BTIG and TD Cowen health care conferences. An important angle for investors is how this rapid revenue expansion, combined with its neoantigen T cell therapy collaboration with Genentech, is shaping perceptions of the company’s commercial and scientific progress. With recent share price moves, we’ll...

AB Volvo reported fourth-quarter 2025 results on January 28, 2026, with sales of SEK 123,803 million and net income of SEK 9,614 million, and its Board proposed an ordinary dividend of SEK 8.50 per share plus an extra dividend of SEK 4.50 per share for full year 2025. The combination of a year-on-year decline in quarterly sales and earnings with a higher total proposed shareholder payout offers a nuanced signal about the company’s capital allocation priorities and confidence in its financial...

Oklo (OKLO) is back in focus after its binding agreement with Meta Platforms to build a 1.2 GW advanced nuclear campus for data centers, a deal that has coincided with fresh government support for nuclear energy. See our latest analysis for Oklo. The Meta agreement and broader policy support have arrived during a volatile stretch for Oklo, with a 27.4% 30 day share price return and a 31.3% decline over 90 days. At the same time, a 167.39% 1 year total shareholder return and a very large 3...

If you are wondering whether Lowe's Companies is attractively priced at its current level, you are not alone. The stock often gets attention from investors trying to work out if the market is being too cautious or too optimistic. The share price recently closed at US$269.42, with a 10.5% return over the last 30 days, a 9.1% return year to date and a 5.0% return over the last year, alongside a 2.8% decline over the past week and a 74.1% return over five years. Recent news coverage has focused...

Bank of Hawaii (BOH) is back in focus after fourth quarter 2025 results topped Wall Street expectations, with higher net interest income, wider net interest margin, disciplined costs, and an affirmed US$0.70 quarterly dividend. See our latest analysis for Bank of Hawaii. Investors have reacted positively to the earnings beat and ongoing buybacks, with the share price at US$74.14 and a 90 day share price return of 14.17%. The 5 year total shareholder return of 14.42% suggests steadier long...

Why Fuji Electric’s revised guidance matters now Fuji Electric (TSE:6504) has updated its earnings outlook for the fiscal year ending March 31, 2026, projecting net sales of ¥1.185t, operating profit of ¥128.5b, and profit attributable to owners of parent of ¥89.0b. The company also guided for profit per share of ¥603.81, giving investors a fresh reference point for assessing how the current share price around ¥11,700 lines up with its latest expectations. See our latest analysis for Fuji...

If you are wondering whether Artivion at around US$41.29 is a fair price or starting to look stretched, you are not alone. This article will focus squarely on what the current share price could mean for value minded investors. The stock has seen a 6.8% decline over the last 7 days and a 10.9% decline over the last 30 days, yet it is still up 32.3% over the past year and has a very large 3 year return alongside a 70.4% return over 5 years. Recent price moves sit against a backdrop of...

Western Union (NYSE:WU) plans to launch a USD stablecoin and a new Digital Asset Network. The company has also announced a pending acquisition of Intermex to expand its retail presence. Both initiatives are aimed at reshaping how Western Union participates in global money movement and remittances. Western Union, long known for cash focused remittances, is now moving deeper into digital assets through a planned USD stablecoin and supporting network. This comes as money transfer activity...

TAL Education Group has released its third-quarter and nine-month results to November 30, 2025, reporting sales of US$770.17 million and US$2.21 billion respectively, alongside sharply higher net income and earnings per share from continuing operations versus a year earlier. The scale of the increase in quarterly net income, rising from US$23.07 million to US$130.6 million, highlights a marked improvement in profitability across the business. We’ll now examine how this strong earnings...

Recent share performance and business snapshot Air Lease (AL) has drawn investor attention after a modest 0.1% decline over the past day, contrasting with small positive moves over the past week, month and past 3 months, and a 42% total return over the past year. The company focuses on purchasing and leasing commercial jet aircraft to airlines worldwide, with additional revenue sources from aircraft sales and fleet management services for third party owners. See our latest analysis for Air...

Why Cascades Stock Is Getting Attention Now Cascades (TSX:CAS) is back on investor radars after recent share price moves, with the stock showing mixed short term returns but a stronger trend over the past 3 months and 3 years. See our latest analysis for Cascades. Recent trading has been relatively muted at around CA$13.07. However, the 30 day share price return of 5.9% and 90 day gain of 18.7% suggest momentum has picked up, alongside a 3 year total shareholder return of 62.7% that reflects...

True Potential Investments has appointed Amundi as its exclusive strategic investment solutions partner for its Growth-Aligned fund range, extending the relationship into asset allocation design, index-level fund integration, and technology, while Amundi also recently named Alessia Berardi as head of global macroeconomics. The partnership brings Amundi’s macro research and ALTO platform directly into True Potential’s portfolio construction process, tightening the link between Amundi’s...

CMS has proposed nearly flat Medicare Advantage payment rates for 2027, affecting plans run by NYSE:HUM and peers. Humana is responding with a greater focus on healthcare access efforts, including a new partnership with Carda Health to expand at-home cardiac rehabilitation. The combination of regulatory pressure and care delivery initiatives is drawing attention from investors, patients, and policymakers. Humana, traded as NYSE:HUM, is a major player in Medicare Advantage, so any shift in...

If you are wondering whether BWX Technologies at around US$216.30 is priced for perfection or still offers value, you are not alone. The share price has moved by 3.2% over the last 7 days, 23.3% over the past 30 days, 18.9% year to date and 94.4% over the past year, with a very large 5 year return that is well over 5x. Recent coverage around BWX Technologies has focused on its role in nuclear and defense related projects, as investors watch how these areas shape future contract pipelines and...

If you are wondering whether ATI's recent run still leaves any value on the table, this article will walk through what the current price could be implying about the stock. ATI closed at US$121.72, with a 7 day return of a 2.4% decline, a 30 day return of 4.4%, a year to date return of 2.1% and a 1 year return of 102.1%. This naturally raises questions about what is already priced in. Recent coverage has focused on ATI as investors reassess the company after a very large 5 year return that is...

In January 2026, Glacier Bancorp reported past fourth-quarter 2025 results showing net interest income of US$266.07 million and net income of US$63.78 million, alongside full-year net interest income of US$889.04 million and net income of US$239.03 million. The bank’s results reflected higher net interest income helped by its recent acquisitions, while net charge-offs rose to US$6.4 million in the quarter, including US$2.2 million in deposit overdraft losses. With Glacier Bancorp...

Eva Live, Inc.'s ( NASDAQ:GOAI ) price-to-sales (or "P/S") ratio of 15.3x may look like a poor investment opportunity...

Key Insights The projected fair value for Swisscom is CHF938 based on 2 Stage Free Cash Flow to Equity Swisscom's...

Key Insights The projected fair value for Koninklijke Ahold Delhaize is €62.24 based on 2 Stage Free Cash Flow to...

SkyWest, Inc.'s ( NASDAQ:SKYW ) price-to-earnings (or "P/E") ratio of 9x might make it look like a strong buy right now...

Key Insights Significant control over Melexis by retail investors implies that the general public has more power to...

Integra LifeSciences Holdings Corporation ( NASDAQ:IART ), is not the largest company out there, but it saw significant...

What Pediatrix Medical Group’s recent performance tells investors Pediatrix Medical Group (MD) has drawn fresh attention after recent share moves, with the stock up about 19% over the past 3 months but softer over the month and year to date. That mixed pattern, together with its latest financial profile, is prompting investors to reassess how this newborn and pediatric care provider fits into a diversified healthcare portfolio. See our latest analysis for Pediatrix Medical Group. At a share...

If you are wondering whether SLB is priced fairly right now, the stock's recent moves and current valuation metrics give you quite a bit to think about. The share price closed at US$48.87, with returns of 0.7% over the past week, 28.9% over the past month, 21.6% year to date, 23.1% over one year, and a 5.4% decline over three years, while the five year return stands at 125.0%. Recent coverage has focused on SLB as a key name in the energy sector, with investors paying close attention to how...